ATI RN
ATI Exit Exam
1. A nurse is assessing a newborn who has a blood glucose level of 30 mg/dl. Which manifestation should the nurse expect?
- A. Loose stools.
- B. Jitteriness.
- C. Hypertonia.
- D. Abdominal distention.
Correct answer: B
Rationale: Jitteriness is a common symptom of neonatal hypoglycemia. When a newborn has a low blood glucose level, they may exhibit signs of central nervous system dysfunction, such as jitteriness. Loose stools (Choice A) are not typically associated with neonatal hypoglycemia. Hypertonia (Choice C) refers to increased muscle tone, which is not a common manifestation of hypoglycemia in newborns. Abdominal distention (Choice D) is more often associated with gastrointestinal issues rather than hypoglycemia.
2. A nurse is planning to administer a blood transfusion to a client. Which of the following should the nurse do to prevent an adverse transfusion reaction?
- A. Verify the client's blood type with the provider's prescription
- B. Ensure the client's consent for the transfusion is on file
- C. Administer a diuretic prior to starting the transfusion
- D. Check the client's temperature prior to the transfusion
Correct answer: A
Rationale: The correct answer is to verify the client's blood type with the provider's prescription. This is crucial to prevent an adverse transfusion reaction due to incompatibility. Ensuring the blood type matches before starting the transfusion is a standard safety practice. Option B, ensuring client consent, is important but not directly related to preventing a transfusion reaction. Option C, administering a diuretic, is unnecessary and can be harmful in this context. Option D, checking the client's temperature, is important for general assessment but not specifically focused on preventing a transfusion reaction.
3. A nurse is caring for a client who has a new prescription for nitroglycerin transdermal patches. Which of the following instructions should the nurse include?
- A. Apply the patch to the same location each time.
- B. Rotate the patch site daily to avoid skin irritation.
- C. Apply the patch in the morning and remove it at bedtime.
- D. Keep the patch on at all times, even during a bath.
Correct answer: C
Rationale: The correct answer is to apply the nitroglycerin transdermal patch in the morning and remove it at bedtime. This schedule helps prevent tolerance to the medication. Choice A is incorrect because the patch should be rotated to different sites to prevent skin irritation. Choice B is incorrect as daily rotation is recommended, not daily application to the same site. Choice D is incorrect as the patch should be removed during a bath as it may decrease the efficacy of the medication.
4. A nurse is caring for a client who is at 38 weeks of gestation and has preeclampsia. Which of the following findings should the nurse report to the provider?
- A. Fetal heart rate of 110/min
- B. 1+ pitting edema
- C. Blood pressure 138/80 mm Hg
- D. Urine output of 20 mL/hr
Correct answer: D
Rationale: The correct answer is D. Urine output less than 30 mL/hr indicates decreased kidney perfusion, which is a serious complication of preeclampsia. Reporting this finding is crucial for prompt intervention. Choices A, B, and C are not the priority as fetal heart rate of 110/min, 1+ pitting edema, and blood pressure of 138/80 mm Hg are within normal limits for a client with preeclampsia at 38 weeks of gestation.
5. Which electrolyte imbalance is most concerning in a patient taking digoxin?
- A. Monitor potassium levels
- B. Monitor calcium levels
- C. Monitor sodium levels
- D. Monitor magnesium levels
Correct answer: A
Rationale: The correct answer is to monitor potassium levels. Patients taking digoxin are at risk of developing toxicity due to hypokalemia. Low potassium levels can potentiate the toxic effects of digoxin on the heart, leading to serious arrhythmias. Monitoring calcium levels (Choice B) is not the primary concern in patients taking digoxin. While calcium levels play a role in cardiac function, hypocalcemia is not directly associated with digoxin toxicity. Monitoring sodium levels (Choice C) is important for other conditions but is not the primary concern in a patient taking digoxin. Monitoring magnesium levels (Choice D) is also essential, but hypomagnesemia is not as directly linked to digoxin toxicity as hypokalemia.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access